XML 72 R61.htm IDEA: XBRL DOCUMENT v3.7.0.1
Segment Disclosures - Summary Information for the Reportable Segments (Details) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Jan. 31, 2017
Mar. 31, 2017
Mar. 31, 2016
Dec. 31, 2016
Segment reporting information, revenues        
Rental Revenues   $ 473,837,000 $ 502,428,000  
HCP's share of earnings   3,269,000 (908,000)  
Operating expenses   (159,081,000) (175,957,000)  
Segment NOI   333,908,000 338,830,000  
Adjustments to NOI   (568,000) (2,450,000)  
Adjusted NOI   333,340,000 336,380,000  
Addback adjustments   568,000 2,450,000  
Interest income   18,331,000 18,029,000  
Interest expense   (86,718,000) (122,062,000)  
Depreciation and amortization   (136,554,000) (139,855,000)  
General and administrative   (22,478,000) (25,451,000)  
Acquisition and pursuit costs   (1,057,000) (2,475,000)  
Gain on sales of real estate, net   317,258,000    
Other income, net   51,208,000 1,292,000  
Income tax expense   6,162,000 (3,704,000)  
Less: HCP share of unconsolidated joint venture NOI   (19,152,000) (12,359,000)  
Equity income in unconsolidated JVs   3,269,000 (908,000)  
Discontinued operations     68,408,000  
Net income   464,177,000 119,745,000  
Corporate and other assets        
Segment reporting information, revenues        
Interest expense   (79,265,000) (105,411,000)  
General and administrative   (22,478,000) (25,451,000)  
Acquisition and pursuit costs   (1,057,000) (2,475,000)  
Other income, net   51,208,000 1,292,000  
Income tax expense   6,162,000 (3,704,000)  
Discontinued operations     68,408,000  
Net income   (45,430,000) (67,341,000)  
Intersegment Eliminations        
Segment reporting information, revenues        
Operating expenses   (60,059,000) (42,614,000)  
Parent Company        
Segment reporting information, revenues        
HCP's share of earnings   79,211,000 54,973,000  
SH NNN        
Segment reporting information, revenues        
Intersegment sales or transfers   1   $ 17
SH NNN | Operating segment        
Segment reporting information, revenues        
Rental Revenues   100,034,000 106,889,000  
Operating expenses   (1,111,000) (2,074,000)  
Segment NOI   98,923,000 104,815,000  
Adjustments to NOI   (1,839,000) (5,443,000)  
Adjusted NOI   97,084,000 99,372,000  
Addback adjustments   1,839,000 5,443,000  
Interest expense   (627,000) (4,166,000)  
Depreciation and amortization   (26,411,000) (33,506,000)  
Gain on sales of real estate, net   268,464,000    
Net income   340,349,000 67,143,000  
SHOP | Operating segment        
Segment reporting information, revenues        
Rental Revenues   140,228,000 165,763,000  
Operating expenses   (94,539,000) (114,003,000)  
Segment NOI   62,526,000 61,949,000  
Adjustments to NOI   3,508,000 5,032,000  
Adjusted NOI   66,034,000 66,981,000  
Addback adjustments   (3,508,000) (5,032,000)  
Interest expense   (4,596,000) (7,855,000)  
Depreciation and amortization   (26,358,000) (26,297,000)  
Gain on sales of real estate, net   366,000    
Less: HCP share of unconsolidated joint venture NOI   (16,837,000) (10,189,000)  
Equity income in unconsolidated JVs   1,993,000 (2,478,000)  
Net income   17,094,000 15,130,000  
SHOP | Intersegment Eliminations        
Segment reporting information, revenues        
Operating expenses   (59,527,000) (42,088,000)  
SHOP | Parent Company | Operating segment        
Segment reporting information, revenues        
HCP's share of earnings   76,364,000 52,277,000  
Life science        
Segment reporting information, revenues        
Gain on sales of real estate, net $ 45,000,000      
Life science | Operating segment        
Segment reporting information, revenues        
Rental Revenues   85,321,000 88,948,000  
Operating expenses   (17,319,000) (16,743,000)  
Segment NOI   69,571,000 73,641,000  
Adjustments to NOI   (256,000) (673,000)  
Adjusted NOI   69,315,000 72,968,000  
Addback adjustments   256,000 673,000  
Interest expense   (104,000) (638,000)  
Depreciation and amortization   (33,791,000) (33,596,000)  
Gain on sales of real estate, net   44,633,000    
Less: HCP share of unconsolidated joint venture NOI   (1,569,000) (1,436,000)  
Equity income in unconsolidated JVs   770,000 709,000  
Net income   79,510,000 38,680,000  
Life science | Intersegment Eliminations        
Segment reporting information, revenues        
Operating expenses   (371,000) (374,000)  
Life science | Parent Company | Operating segment        
Segment reporting information, revenues        
HCP's share of earnings   1,940,000 1,810,000  
Medical office | Operating segment        
Segment reporting information, revenues        
Rental Revenues   118,371,000 108,023,000  
Operating expenses   (44,864,000) (41,949,000)  
Segment NOI   73,854,000 66,404,000  
Adjustments to NOI   (969,000) (795,000)  
Adjusted NOI   72,885,000 65,609,000  
Addback adjustments   969,000 795,000  
Interest expense   (129,000) (1,665,000)  
Depreciation and amortization   (42,729,000) (38,719,000)  
Less: HCP share of unconsolidated joint venture NOI   (347,000) (330,000)  
Equity income in unconsolidated JVs   269,000 658,000  
Net income   30,918,000 26,348,000  
Medical office | Intersegment Eliminations        
Segment reporting information, revenues        
Operating expenses   (142,000) (149,000)  
Medical office | Parent Company | Operating segment        
Segment reporting information, revenues        
HCP's share of earnings   489,000 479,000  
Other Non-reportable segments | Operating segment        
Segment reporting information, revenues        
Rental Revenues   29,883,000 32,805,000  
Operating expenses   (1,248,000) (1,188,000)  
Segment NOI   29,034,000 32,021,000  
Adjustments to NOI   (1,012,000) (571,000)  
Adjusted NOI   28,022,000 31,450,000  
Addback adjustments   1,012,000 571,000  
Interest income   18,331,000 18,029,000  
Interest expense   (1,997,000) (2,327,000)  
Depreciation and amortization   (7,265,000) (7,737,000)  
Gain on sales of real estate, net   3,795,000    
Less: HCP share of unconsolidated joint venture NOI   (399,000) (404,000)  
Equity income in unconsolidated JVs   237,000 203,000  
Net income   41,736,000 39,785,000  
Other Non-reportable segments | Intersegment Eliminations        
Segment reporting information, revenues        
Operating expenses   (19,000) (3,000)  
Other Non-reportable segments | Parent Company | Operating segment        
Segment reporting information, revenues        
HCP's share of earnings   $ 418,000 $ 407,000